Related Experiment Videos
A nitric oxide production bioassay for interferon-gamma
1Department of Surgery and Pharmacology, University of Pittsburgh, School of Medicine, PA 15213, USA.
Journal of Immunological Methods
|November 13, 1996
Summary
A new bioassay detects Interferon-gamma (IFN-gamma) by measuring nitric oxide (NO) produced by macrophages. This sensitive and specific method offers a simple, cost-effective way to monitor IFN-gamma levels for therapeutic applications.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Interferon-gamma (IFN-gamma) exhibits antitumor and antiviral properties.
- Existing IFN-gamma assays lack simplicity, cost-effectiveness, and specificity.
Purpose of the Study:
- To develop a novel, simple, inexpensive, and specific bioassay for quantifying Interferon-gamma (IFN-gamma).
- To measure IFN-gamma bioactivity by assessing nitric oxide (NO) production in macrophages.
Main Methods:
- Utilized a macrophage cell line (RAW264.7) stimulated with IFN-gamma.
- Quantified nitric oxide (NO) production via nitrite (NO2-) accumulation in culture medium.
- Validated assay sensitivity, specificity, and correlation with ELISA for IFN-gamma protein concentration.
Main Results:
- Developed a linear and logarithmically linear bioassay for IFN-gamma detection (0-10 U/ml and 2-100 U/ml, respectively).
- Achieved high sensitivity with a detection limit of 0.1-0.2 ng/ml IFN-gamma.
- Demonstrated specificity as other cytokines did not induce NO production; assay results correlated well with ELISA.
Conclusions:
- The developed bioassay is a sensitive, specific, and cost-effective method for measuring IFN-gamma bioactivity.
- This novel assay is suitable for monitoring IFN-gamma gene expression and protein accumulation in various research and therapeutic contexts.
- The method provides a valuable tool for advancing IFN-gamma-based therapies.